Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea FDA Bans 1000-plus Products During Probe Into Asbestos

This article was originally published in PharmAsia News

Executive Summary

 

You may also be interested in...



S. Korea Doubles Number Of Asbestos-Tainted Drugs Allowed On Sale

South Korea's FDA has decided to add 11 more drugs believed tainted with asbestos to remain for sale through May 8. The decision increases the number of asbestos-tainted medicines allowed to remain on the market to 22 out of the 1,122 identified by the agency as possibly contaminated with the carcinogen (PharmAsia News, April 10, 2009). The agency eased the restrictions for the 22 on grounds there were no suitable replacements for them. The other 1,100 drugs have been banned and removed from store shelves if they were made before April 3, when the agency issued a ban on the use of talc to remove asbestos. (Click here for more

S. Korea Doubles Number Of Asbestos-Tainted Drugs Allowed On Sale

South Korea's FDA has decided to add 11 more drugs believed tainted with asbestos to remain for sale through May 8. The decision increases the number of asbestos-tainted medicines allowed to remain on the market to 22 out of the 1,122 identified by the agency as possibly contaminated with the carcinogen (PharmAsia News, April 10, 2009). The agency eased the restrictions for the 22 on grounds there were no suitable replacements for them. The other 1,100 drugs have been banned and removed from store shelves if they were made before April 3, when the agency issued a ban on the use of talc to remove asbestos. (Click here for more

KFDA Under Fire Over Dawdle In Fight Against Asbestos-tainted Talc Pills

SEOUL - South Korea's FDA is under fire after announcing it would expand a probe into pharmaceutical pills to determine how asbestos-tainted talc was used to prevent the pills from sticking to each other in the production process

UsernamePublicRestriction

Register

ID052006

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel